Free Trial
NASDAQ:BFRG

Bullfrog AI Q3 2025 Earnings Results & Report

Bullfrog AI logo
$0.54 -0.01 (-2.08%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$0.53 -0.01 (-1.39%)
As of 11/13/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bullfrog AI reported Q3 2025 earnings on November 14, 2025. The company reported EPS of -$0.15, while revenue was $166.83 thousand.

Earnings Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call
7:00 AM ET

Bullfrog AI EPS Results

Actual EPS
-$0.15
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bullfrog AI Revenue Results

Actual Revenue
$166.83 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

Bullfrog AI Q3 2025 Earnings FAQ

Bullfrog AI (NASDAQ:BFRG) reported earnings of -$0.15 per share for Q3 2025. The report was announced on Friday, November 14, 2025.

Bullfrog AI reported revenue of $166.83 thousand for Q3 2025.

Bullfrog AI Earnings Headlines

Bullfrog AI (BFRG) Expected to Release Quarterly Earnings on Friday
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
See More Bullfrog AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bullfrog AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bullfrog AI and other key companies, straight to your email.

About Bullfrog AI

Bullfrog AI (NASDAQ:BFRG) Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine.

Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.

The company has positioned its business around applying artificial intelligence to areas such as oncology, neurological disorders and other complex diseases. BullFrog AI is headquartered in the United States and primarily operates in the healthcare and biotechnology markets, working with organizations that need advanced analytics for biomedical research and drug-development programs.

View Bullfrog AI Profile